- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Aug 14, 2020 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Aug 17, 2020 | T-1845-17 | MED | Patterned Concrete Mississauga Inc. V. Bomanite Toronto Ltd. (Copyright) | Toronto | 1 d |
| Aug 17, 2020 | T-954-18 | TMC | Deeproot Green Infrastructure, Llc Et Al V. Greenblue Urban North America In (Patent) | Toronto | 2 h |
| Aug 18, 2020 | T-1198-18 | CMC | Vancouver Assoc. For Injured Motorcyclists V. Interior Bc Assoc. For Injured (Trade Mark) | Vancouver | 1 h |
| Aug 18, 2020 | T-1830-19 | CMC | Bristol-myers Squibb Canada Co., Et Al V. Jamp Pharma Corporation (Patent - Apixaban*) | Toronto | 30 m |
| Aug 18, 2020 | T-315-20 | CMC | Sunovion Pharmaceuticals Canada Inc. Et Al V. Pharmascience Inc. (Patent - Lurasidone*) | Toronto | 30 m |
| Aug 19, 2020 | T-1636-18 | M | Depura Partners Llc's V. Desjardins General Insurance Inc. Et Al (Patent) | Ottawa | 2 h |
| Aug 20, 2020 | T-1187-19 | CMC | Bayer Inc. And Other V. Dr. Reddy's Laboratories Ltd And Others (Patent - Rivaroxaban*) | Ottawa | 1 h |
| Aug 20, 2020 | T-1434-14 | M | Pharmascience Inc. V. Pfizer Canada Ulc (PMNOC - Section 8 - Pregabalin*) | Toronto | 1 d |
| Aug 20, 2020 | T-875-16 | M | Pliteq, Inc. V. Ecore International, Inc Et Al (Trade Mark) | Ottawa | 2 h |
| Aug 20, 2020 | T-769-20 | CMC | Janssen Inc. Et Al. V. Jamp Pharma Corporation (Patent - Macitentan*) | Toronto | 30 m |
| Aug 21, 2020 | T-1158-18 | PTC | Maoz Betser-zilevitch V. Petrochina Canada Ltd. (Patent) | Ottawa | 1 h |
| Aug 21, 2020 | T-1085-15 | CMC | 1395804 Ontario Ltd., Operation As Blacklock's Reporter V. Agc (unknown) | Ottawa | 1 h |
| Aug 21, 2020 | T-1228-17 | CMC | 1395804 Ontario Ltd. O/a Blacklock's Reporter V. Via Rail Canada Inc. (Copyright) | Ottawa | 1 h |
| Aug 21, 2020 | T-132-17 | CMC | 1395804 Ontario Ltd., Operaring As Blacklock's Reporter V. Agc (unknown) | Ottawa | 1 h |
| Aug 21, 2020 | T-133-17 | CMC | 1395804 Ontario Ltd., Operating As Blacklock's Reporter V. Agc (unknown) | Ottawa | 1 h |
| Aug 21, 2020 | T-134-17 | CMC | 1395804 Ontario Ltd V. Financial Transactions And Reports Analysis Centre (unknown) | Ottawa | 1 h |
| Aug 21, 2020 | T-1726-15 | CMC | 1395804 Ontario Ltd Et Al V. Library Of Parliament (Copyright) | Ottawa | 1 h |
| Aug 21, 2020 | T-1862-15 | CMC | 1395804 Ontario Ltd. V. The Attorney General Of Canada (Copyright) | Ottawa | 1 h |
| Aug 21, 2020 | T-2042-16 | CMC | 1395804 Ontario Ltd., Operating As Blacklock's Reporter V. Agc (Copyright) | Ottawa | 1 h |
| Aug 21, 2020 | T-2090-14 | CMC | 1395804 Ontario Ltd V. Canada (ag) (Copyright) | Ottawa | 1 h |
| Aug 21, 2020 | T-897-15 | CMC | 1395804 Ontario Ltd. V. Canadian Transportion Agency (Copyright) | Ottawa | 1 h |
| Aug 21, 2020 | T-943-17 | CMC | 1395804 Ontario Ltd. V. National Energy Board (Copyright) | Ottawa | 1 h |
| Aug 21, 2020 | T-827-20 | CMC | Viiv Healthcare Company, Shionogi & Co., Ltd. Et Al. V. Sandoz Canada Inc. (Patent - DOLUTEGRAVIR*) | Toronto | 30 m |
| Aug 21, 2020 | T-503-19 | CMC | Bristol-myers Squibb Canada Co. Et Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 30 m |
| Aug 21, 2020 | T-504-19 | CMC | Bristol-myers Squibb Canada Co. El Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 30 m |
| Aug 21, 2020 | T-97-19 | CMC | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience (Patent - Apixaban*) | Toronto | 30 m |
| Aug 21, 2020 | T-98-19 | CMC | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience Inc. (Patent - Apixaban*) | Toronto | 30 m |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Sep 1, 2020 | T-2093-18 | Bayer Inc. Et Al V. Apotex Inc. (Trade Mark - Rivaroxaban*) | Ottawa | 11 d |
| Sep 1, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Ottawa | 11 d |
| Sep 1, 2020 | T-806-19 | Bayer Inc Et Al. V. Sandoz Canada Inc. (Patent - Rivaroxaban*) | Ottawa | 11 d |
| Sep 1, 2020 | T-435-19 | Bayer Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Rivaroxaban*) | Ottawa | 11 d |
| Sep 14, 2020 | T-504-19 | Bristol-myers Squibb Canada Co. El Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-503-19 | Bristol-myers Squibb Canada Co. Et Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-98-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-97-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience (Patent - Apixaban*) | Toronto | 17 d |
| Sep 21, 2020 | T-2183-18 | Teva Canada Innovation And Others V. Pharmascience Inc. And Others (Patent - Glatiramer*) | Toronto | 10 d |
| Sep 21, 2020 | T-2182-18 | Teva Canada Innovation Et Al. V. Pharmascience Et Al. (Patent - Glatiramer*) | Toronto | 10 d |
| Sep 22, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Ottawa | 4 d |
| Sep 28, 2020 | T-448-17 | Guest Tek Interactive Entertainment Ltd. V. Nomadix, Inc. (Patent) | Calgary | 14 d |
| Oct 6, 2020 | T-2093-18 | Bayer Inc. Et Al V. Apotex Inc. (Trade Mark - Rivaroxaban*) | Ottawa | 4 d |
| Oct 13, 2020 | T-954-18 | Deeproot Green Infrastructure, Llc Et Al V. Greenblue Urban North America In (Patent) | Toronto | 13 d |
| Oct 14, 2020 | T-2183-18 | Teva Canada Innovation And Others V. Pharmascience Inc. And Others (Patent - Glatiramer*) | Toronto | 2 d |
| Oct 14, 2020 | T-2182-18 | Teva Canada Innovation Et Al. V. Pharmascience Et Al. (Patent - Glatiramer*) | Toronto | 2 d |
| Oct 14, 2020 | T-921-17 | Rovi Guides, Inc. Et Al V. Videotron Ltd. (Patent) | Toronto | 3 d |
| Oct 26, 2020 | T-182-19 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-84-19 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-2023-18 | Allergan Inc. V. Sandoz Canada Inc. Et Al (Patent - Silodosin*) | Toronto | 8 d |
| Oct 26, 2020 | T-1893-19 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-978-19 | Janssen Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 29, 2020 | T-206-18 | Rovi Guides, Inc. Et Al V. Telus Corporation Et Al (Patent) | Toronto | 2 d |
| Oct 29, 2020 | T-113-18 | Rovi Guides Inc Et Al V. Bce Inc. Et Al (Patent) | Toronto | 2 d |
| Nov 12, 2020 | T-2023-18 | Allergan Inc. V. Sandoz Canada Inc. Et Al (Patent - Silodosin*) | Toronto | 2 d |
| Nov 16, 2020 | T-227-17 | Dtechs Epm Ltd. V. British Columbia Hydro And Power Authority Et Al. (Patent) | Vancouver | 10 d |
| Nov 17, 2020 | T-168-18 | Lickerish, Ltd. V. Airg Inc. (Copyright) | Calgary | 3 d |
| Nov 23, 2020 | T-917-17 | Sse Holdings, Llc Et Al V. Le Chic Shack Inc. (Trade Mark) | Québec | 5 d |
| Nov 30, 2020 | T-1184-17 | Merck Sharp & Dohme Corp.et Al V. Wyeth Llc (Patent - Pneumococcal*) | Toronto | 10 d |
| Nov 30, 2020 | T-1158-18 | Maoz Betser-zilevitch V. Petrochina Canada Ltd. (Patent) | Toronto | 12 d |
| Dec 3, 2020 | T-311-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Dba Reebok-ccm Hockey (Trade Mark) | Montréal | 14 d |
| Jan 11, 2021 | T-708-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 11, 2021 | T-706-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - PIRFENIDONE*) | Toronto | 10 d |
| Jan 11, 2021 | T-705-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 11, 2021 | T-704-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 11, 2021 | T-1948-16 | Upper Canada Forest Products Ltd V. Bramwood Forest Inc. (Trade Mark) | Toronto | 5 d |
| Jan 11, 2021 | T-435-19 | Bayer Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Rivaroxaban*) | Ottawa | 5 d |
| Jan 18, 2021 | T-151-16 | Angelcare Development Inc. Et Al. V. Munchkin, Inc Et Al. (Patent) | Montréal | 40 d |
| Feb 1, 2021 | T-794-19 | Allergan Inc. Et Al V. Apotex Inc. (Patent - Risedronate*) | Toronto | 10 d |
| Feb 1, 2021 | T-1434-14 | Pharmascience Inc. V. Pfizer Canada Ulc (PMNOC - Section 8 - Pregabalin*) | Toronto | 30 d |
| Feb 1, 2021 | T-396-13 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 5 d |
| Feb 1, 2021 | T-806-19 | Bayer Inc Et Al. V. Sandoz Canada Inc. (Patent - Rivaroxaban*) | Ottawa | 5 d |
| Feb 8, 2021 | T-1004-18 | Akebia Therapeutics, Inc. V. Fibrogen, Inc. (Patent) | Toronto | 12 d |
| Feb 15, 2021 | T-898-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-897-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-896-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-770-19 | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-768-19 | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-152-17 | Milano Pizza Ltd. V. 6034799 Canada Inc Et Al (Trade Mark) | Ottawa | 7 d |
| Feb 15, 2021 | T-1008-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-1007-19 | Hoffmann-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-943-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-942-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-941-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-939-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-899-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Mar 8, 2021 | T-396-13 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 10 d |
| Mar 22, 2021 | T-1187-19 | Bayer Inc. And Other V. Dr. Reddy's Laboratories Ltd And Others (Patent - Rivaroxaban*) | Ottawa | 9 d |
| Mar 29, 2021 | T-396-13 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 2 d |
| Apr 12, 2021 | T-1837-18 | Canplas Industries Ltd. V. Lomanco Inc. Et Al (Patent) | Toronto | 10 d |
| Apr 19, 2021 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Vancouver | 15 d |
| May 3, 2021 | T-123-15 | Bauer Hockey Corp. V. Sport Maska Inc. D.b.a. Ccm Hockey (Patent) | Ottawa | 38 d |
| May 3, 2021 | T-1316-19 | Allergan Inc. V. Apotex Inc. Et Al. (Patent - Ulipristal*) | Toronto | 14 d |
| May 3, 2021 | T-1315-19 | Allergan Inc. V. Apotex Inc. Et Al. (Patent - Ulipristal*) | Toronto | 14 d |
| Jun 14, 2021 | T-40-18 | Paid Search Engine Tools, Llc V. Google Canada Corporation Et Al (Patent) | Ottawa | 13 d |
| Jun 14, 2021 | T-1749-19 | Searchlight Pharma Inc. C. Jamp Pharma Corporation (Patent - Darifenacin*) | Montréal | 8 d |
| Jun 28, 2021 | T-1749-19 | Searchlight Pharma Inc. C. Jamp Pharma Corporation (Patent - Darifenacin*) | Montréal | 2 d |
| Jul 5, 2021 | T-40-18 | Paid Search Engine Tools, Llc V. Google Canada Corporation Et Al (Patent) | Ottawa | 2 d |
| Jul 19, 2021 | T-1642-16 | Fluid Energy Group Ltd. V. Mud Master Drilling Fluid Services Ltd. (Patent) | Calgary | 10 d |
| Aug 23, 2021 | T-1952-19 | Bausch Health Ireland Ltd., Et Al. V. Teva Canada Limited (Patent - Efinaconazole*) | Toronto | 10 d |
| Aug 30, 2021 | T-913-17 | Canadian National Railway Company V. Bnsf Railway Company Et Al. (Patent) | Toronto | 15 d |
| Sep 1, 2021 | T-2072-19 | Boehringer Ingelheim (canada) Ltd. Et Al V. Teva Canada Limited (Patent - Aftinib*) | Toronto | 11 d |
| Sep 13, 2021 | T-1830-19 | Bristol-myers Squibb Canada Co., Et Al V. Jamp Pharma Corporation (Patent - Apixaban*) | Toronto | 10 d |
| Sep 27, 2021 | T-454-20 | Bausch Health Ireland Ltd. Et Al. V. Taro Pharmaceuticals Inc. (Patent - Efinaconazole*) | Toronto | 10 d |
| Oct 12, 2021 | T-28-20 | Astrazeneca Canada Inc. Et Al V. Sandoz Canada Inc. (Patent - Saxagliptin*) | Toronto | 9 d |
| Oct 18, 2021 | T-34-20 | Amgen Inc. Et Al V. Purdue Pharma (Patent - Pegfilgrastim*) | Toronto | 10 d |
| Oct 18, 2021 | T-65-20 | Astellas Pharma Canada Inc. Et. Al. V. Sandoz Canada Inc. (Patent - Mirabegron*) | Toronto | 10 d |
| Oct 25, 2021 | T-1606-18 | Richards Packaging Inc. V. Distrimedic Inc (Patent) | Montréal | 15 d |
| Nov 1, 2021 | T-315-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Pharmascience Inc. (Patent - Lurasidone*) | Toronto | 10 d |
| Nov 15, 2021 | T-353-20 | Celgene Inc. Et Al V. Natco Pharma (canada)inc. (Patent - Pomalidomide*) | Toronto | 15 d |
| Nov 16, 2021 | T-347-20 | Eisai Limited Et Al V. Taro Pharmaceuticals Inc. (Patent - Perampanel*) | Toronto | 11 d |
| Dec 2, 2021 | T-419-20 | Merck Sharp & Dohme Corp Et Al. V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 12 d |
| Dec 2, 2021 | T-418-20 | Merck Sharp & Dohme Corp Et Al. V. Sandoz Canada Inc (Patent - Sitagliptin*) | Toronto | 12 d |
| Dec 6, 2021 | T-493-20 | Allergan Inc. V. Jamp Pharma Corporation Et Al. (Patent - Ulipristal*) | Toronto | 10 d |
| Dec 6, 2021 | T-492-20 | Allergan Inc. V. Jamp Pharma Corporation Et Al. (Patent - Ulipristal*) | Toronto | 10 d |
| Jan 10, 2022 | T-453-20 | Bausch Health Ireland Ltd. Et Al. V. Taro Pharmaceuticals Inc. (Patent - Efinaconazole*) | Toronto | 10 d |
| Jan 17, 2022 | T-511-20 | Celgene Inc. Et Al. V. Dr. Reddy's Laboratories Ltd. (Patent - Pomalidomide*) | Toronto | 10 d |
| Jan 17, 2022 | T-510-20 | Celgene Inc. Et Al. V. Dr. Reddy's Laboratories Ltd. (Patent - Pomalidomide*) | Toronto | 10 d |
| Jan 24, 2022 | T-549-20 | Janssen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Macitentan*) | Toronto | 7 d |
| Feb 7, 2022 | T-555-20 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Apixaban*) | Toronto | 5 d |
| Feb 14, 2022 | T-649-20 | Hoffmann-la Roche Ltd Et Al. V. Teva Canada Ltd (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 14, 2022 | T-494-20 | Allergan Inc. V. Pharmascience Inc. Et Al. (Patent - Ulipristal*) | Toronto | 10 d |
| Feb 14, 2022 | T-578-20 | Galderma Canada, Inc. Et Al. V. Taro Pharmaceuticals Inc. (Patent - Adapalene*) | Toronto | 10 d |
| Feb 28, 2022 | T-666-20 | Merck Sharp & Dohme Corp Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-665-20 | Merck Sharp & Dohme Corp Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-563-20 | Merck Sharp & Dohme Corp. Et Al V Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-561-20 | Merck Sharp & Dohme Corp. Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-560-20 | Merck Sharp& Dohme Corp Et Al V. Apotex Inc (Patent - Sitagliptin*) | Toronto | 10 d |
| Mar 28, 2022 | T-667-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 10 d |
| Mar 28, 2022 | T-798-20 | Opiant Pharmaceuticals Inc. Et Al V. Teva Canada Ltd. (Patent) | Toronto | 10 d |
| Apr 25, 2022 | T-605-20 | Bayer Inc. Et Al. V. Mint Pharmaceuticals Inc. (Patent - Rivaroxaban*) | Ottawa | 10 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Aug 31, 2020 | T-827-19 | Janssen Inc V. Attorney General Of Canada Et Al | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Sep 1, 2020 | T-1506-19 | Cpas Of Ontario V. American Institute Of Certified Public Accountants | Trade Mark - Appeal of a decision of the Registrar | Toronto | 2 h |
| Sep 8, 2020 | T-293-19 | David Michaels V. Unitop Spolka Z Ograniczona Odpowiedzialnoscia | Trade Mark - Appeal of a decision of the Registrar | Toronto | 3 h |
| Sep 24, 2020 | T-1589-19 | Smart Cloud Inc. V. International Business Machines Corporation | Trade Mark - Appeal of a decision of the Registrar | Toronto | 1 d |
| Sep 30, 2020 | T-17-19 | Tokai Of Canada Ltd. V. The Kingsford Products Company, Llc | Trade Mark - Appeal of a decision of the Registrar | Toronto | 1 d |
| Oct 5, 2020 | T-1487-18 | Abbott Laboratories, Limited V. Agc Et Al | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Oct 6, 2020 | T-1232-19 | Abbott Laboratories, Limited V. Minister Of Health Et Al | Access to Information | Toronto | 1 d |
| Oct 13, 2020 | T-1645-17 | Caterpillar Inc. V. Puma Se | Trade Mark Opposition | Toronto | 1 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Sep 9, 2020 | A-481-19 | Western Oilfield Equipment Rentals Ltd. Et Al. V M-i L.l.c. | Appeal (S.27 - Final) - Patent Act [from T-1056-15 - Patent Impeachment] | Ottawa | 1 d |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.